What is Familial Pancreatic Cancer?
What is familial GIST?
ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Cancer.Net’s Guide to Eyelid Cancer. To see other pages, use the menu on the side of your screen. Think of that menu as a roadmap to this full guide.
What is Peutz-Jeghers syndrome?
What is neurofibromatosis type 1?
What is neurofibromatosis type 2?
Neurofibromatosis type 2 (NF2) is a hereditary condition most commonly associated with bilateral vestibular schwannomas, also known as acoustic neuromas. These are benign (noncancerous) tumors that occur on the nerves for balance leading to the inner ear. Although these tumors are benign, they can cause hearing and balance problems.
What is hereditary mixed polyposis syndrome?
Hereditary mixed polyposis syndrome (HMPS) is a hereditary condition that is associated with an increased risk of developing polyps in the digestive tract, most commonly in the colon and/or rectum. A polyp is a growth of normal tissue that forms a lump. As the name suggests, a variety of polyps may occur. People with HMPS are thought to have an increased risk of developing colorectal cancer, since some of these polyps may turn into cancer over time, unless they are removed.
What is ataxia-telangiectasia?
Ataxia-telangiectasia (A-T) is a hereditary condition characterized by progressive neurologic problems that lead to difficulty walking and an increased risk of developing various types of cancer. Signs of A-T often develop in childhood. Children with A-T may begin staggering and appear unsteady (called ataxia) shortly after learning to walk. Most people with A-T will eventually need to use a wheelchair.
What is Birt-Hogg-Dubé syndrome?
Birt-Hogg-Dubé syndrome (BHD) is a hereditary condition associated with multiple noncancerous (benign) skin tumors, lung cysts, and an increased risk of both benign kidney tumors and kidney cancer. Symptoms of BHD generally do not appear until adulthood.
What is Li-Fraumeni syndrome?
The Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome first reported in 1969 by Drs. Frederick Li and Joseph Fraumeni from the National Cancer Institute. What caught their attention was the wide range of cancers found in affected families, the inherited higher risk of developing cancer across several generations, and the relatively early age of the cancer diagnosis with nearly half of affected individuals having a cancer diagnosis before age 30.